Stem cells hold promise for understanding human disease, screening for novel therapeutics, and regenerating damaged tissues. However, the mechanisms underlying how these cells form and are activated are still being uncovered, and the development of stem cell-derived tissues for drug screening and transplantation is a work in progress. This conversation with leaders in the field explores the fundamentals of stem cell biology, current stem cell-based therapies, and the ethical considerations shaping the future of stem cell research and its clinical applications.
Panel Members
-
Lorenz Studer, Director, Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center
-
Sarah E. Millar, Dean for Academic and Scientific Affairs and Chair of the new Department of Stem Cell Biology and Regenerative Medicine, Icahn School of Medicine at Mount Sinai
In conversation with
-
Kirsten Sadler Edepli, Professor of Biology, NYUAD; Global Network Professor of Biology, NYU
